Literature DB >> 16618421

Recurrent clostridium difficile.

Seema Maroo1, J Thomas Lamont.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16618421     DOI： 10.1053/j.gastro.2006.02.044

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  48 in total

1.  SpoIIID-mediated regulation of σK function during Clostridium difficile sporulation.

Authors:  Keyan Pishdadian; Kelly A Fimlaid; Aimee Shen
Journal:  Mol Microbiol       Date:  2014-12-19       Impact factor: 3.501

2.  Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.

Authors:  Fnu Rafiullah; Sunil Kanwal; Usman M Majeed; Mark A Korsten; Faisal H Cheema; Munish Luthra; Muhammad Rizwan Sohail
Journal:  BMJ Case Rep       Date:  2011-11-21

Review 3.  Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance.

Authors:  Robert A Britton; Vincent B Young
Journal:  Trends Microbiol       Date:  2012-05-15       Impact factor: 17.079

4.  Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.

Authors:  Robert J Gianotti; Alan C Moss
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-04

Review 5.  Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission.

Authors:  Aimee Shen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 6.  Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Gut Microbes       Date:  2013-12-11

7.  Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.

Authors:  Wasef Na'amnih; Amos Adler; Tamar Miller-Roll; Dani Cohen; Yehuda Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-07       Impact factor: 3.267

8.  Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.

Authors:  Andrada Seicean; Anca Moldovan-Pop; Radu Seicean
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Impact of malignancy on Clostridium difficile infection.

Authors:  M S Chung; J Kim; J O Kang; H Pai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-26       Impact factor: 3.267

10.  Evolving concepts in Clostridium difficile colitis.

Authors:  Naomi G Diggs; Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.